参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/04/16 | 1,662 | 1,677 | 1,652 | 1,660 | +8 | +0.5% | 965,000 |
2019/04/15 | 1,655 | 1,665 | 1,642 | 1,652 | +32 | +2% | 1,124,800 |
2019/04/12 | 1,633 | 1,633 | 1,597 | 1,620 | -32 | -1.9% | 1,388,800 |
2019/04/11 | 1,631 | 1,670 | 1,628 | 1,652 | +36 | +2.2% | 1,401,500 |
2019/04/10 | 1,606 | 1,623 | 1,603 | 1,616 | -7 | -0.4% | 629,100 |
2019/04/09 | 1,628 | 1,628 | 1,609 | 1,623 | -12 | -0.7% | 739,400 |
2019/04/08 | 1,636 | 1,648 | 1,622 | 1,635 | +11 | +0.7% | 797,700 |
2019/04/05 | 1,629 | 1,644 | 1,620 | 1,624 | -19 | -1.2% | 1,292,700 |
2019/04/04 | 1,662 | 1,665 | 1,635 | 1,643 | -34 | -2% | 1,146,100 |
2019/04/03 | 1,669 | 1,680 | 1,647 | 1,677 | +8 | +0.5% | 951,400 |
2019/04/02 | 1,700 | 1,700 | 1,669 | 1,669 | -8 | -0.5% | 742,100 |
2019/04/01 | 1,685 | 1,693 | 1,667 | 1,677 | +28 | +1.7% | 1,059,700 |
2019/03/29 | 1,653 | 1,669 | 1,649 | 1,649 | +15 | +0.9% | 1,020,500 |
2019/03/28 | 1,655 | 1,667 | 1,620 | 1,634 | -38 | -2.3% | 907,700 |
2019/03/27 | 1,663 | 1,685 | 1,661 | 1,672 | +8 | +0.5% | 1,295,600 |
2019/03/26 | 1,608 | 1,670 | 1,603 | 1,664 | +67 | +4.2% | 1,776,800 |
2019/03/25 | 1,594 | 1,605 | 1,582 | 1,597 | -27 | -1.7% | 1,320,200 |
2019/03/22 | 1,627 | 1,630 | 1,610 | 1,624 | -16 | -1% | 1,478,200 |
2019/03/20 | 1,649 | 1,651 | 1,615 | 1,640 | -13 | -0.8% | 1,444,600 |
2019/03/19 | 1,672 | 1,672 | 1,648 | 1,653 | -32 | -1.9% | 906,100 |
2019/03/18 | 1,688 | 1,688 | 1,670 | 1,685 | +9 | +0.5% | 1,167,700 |
2019/03/15 | 1,656 | 1,693 | 1,653 | 1,676 | +22 | +1.3% | 1,961,100 |
2019/03/14 | 1,688 | 1,699 | 1,654 | 1,654 | -18 | -1.1% | 1,390,900 |
2019/03/13 | 1,692 | 1,703 | 1,664 | 1,672 | -24 | -1.4% | 1,055,900 |
2019/03/12 | 1,675 | 1,709 | 1,671 | 1,696 | +44 | +2.7% | 1,860,700 |
2019/03/11 | 1,674 | 1,681 | 1,647 | 1,652 | -22 | -1.3% | 1,651,500 |
2019/03/08 | 1,700 | 1,709 | 1,668 | 1,674 | -56 | -3.2% | 2,132,800 |
2019/03/07 | 1,728 | 1,737 | 1,718 | 1,730 | -16 | -0.9% | 1,891,900 |
2019/03/06 | 1,760 | 1,765 | 1,737 | 1,746 | +15 | +0.9% | 2,323,500 |
2019/03/05 | 1,727 | 1,738 | 1,713 | 1,731 | -26 | -1.5% | 2,340,400 |
2019/03/04 | 1,774 | 1,790 | 1,752 | 1,757 | -13 | -0.7% | 2,373,300 |
2019/03/01 | 1,735 | 1,775 | 1,734 | 1,770 | +35 | +2% | 1,944,800 |
2019/02/28 | 1,714 | 1,744 | 1,708 | 1,735 | +14 | +0.8% | 4,066,200 |
2019/02/27 | 1,698 | 1,728 | 1,681 | 1,721 | +32 | +1.9% | 2,860,300 |
2019/02/26 | 1,676 | 1,693 | 1,674 | 1,689 | +13 | +0.8% | 2,108,200 |
2019/02/25 | 1,657 | 1,682 | 1,653 | 1,676 | +33 | +2% | 2,122,300 |
2019/02/22 | 1,640 | 1,660 | 1,629 | 1,643 | -5 | -0.3% | 2,066,800 |
2019/02/21 | 1,689 | 1,691 | 1,630 | 1,648 | +79 | +5% | 4,285,400 |
2019/02/20 | 1,560 | 1,580 | 1,544 | 1,569 | +8 | +0.5% | 1,231,200 |
2019/02/19 | 1,562 | 1,568 | 1,551 | 1,561 | +2 | +0.1% | 895,000 |
2019/02/18 | 1,555 | 1,568 | 1,542 | 1,559 | +31 | +2% | 1,085,000 |
2019/02/15 | 1,516 | 1,535 | 1,511 | 1,528 | +4 | +0.3% | 1,035,800 |
2019/02/14 | 1,526 | 1,535 | 1,523 | 1,524 | +14 | +0.9% | 1,221,300 |
2019/02/13 | 1,526 | 1,529 | 1,505 | 1,510 | -13 | -0.9% | 1,729,600 |
2019/02/12 | 1,480 | 1,533 | 1,477 | 1,523 | +59 | +4% | 1,293,900 |
2019/02/08 | 1,475 | 1,482 | 1,450 | 1,464 | -23 | -1.5% | 1,077,500 |
2019/02/07 | 1,519 | 1,523 | 1,477 | 1,487 | -35 | -2.3% | 1,065,900 |
2019/02/06 | 1,548 | 1,571 | 1,519 | 1,522 | -19 | -1.2% | 1,303,200 |
2019/02/05 | 1,545 | 1,553 | 1,525 | 1,541 | ±0 | ±0% | 1,143,100 |
2019/02/04 | 1,540 | 1,562 | 1,531 | 1,541 | +11 | +0.7% | 999,800 |
1551~
1600
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.21倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム